Advertisement
Advertisement
U.S. Markets open in 5 hrs 34 mins
Advertisement
Advertisement
Advertisement
Advertisement

Theratechnologies Inc. (THTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.2500+0.1200 (+3.83%)
At close: 03:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.1300
Open3.1400
Bid0.0000 x 2900
Ask0.0000 x 3200
Day's Range3.1103 - 3.2800
52 Week Range2.0900 - 4.4600
Volume99,137
Avg. Volume152,251
Market Cap309.231M
Beta (5Y Monthly)1.78
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV

    sBLA submission with FDA follows on the back of recently announced positive TMB-302 study resultsMONTREAL, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce the submission of a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for the Company’s intravenous (IV) pu

  • GlobeNewswire

    Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category

    MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021. Every year, the ADRIQ (Association pour le développement de la recherche et de l'innovation du Québec

  • CNW Group

    Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended

    Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities of all the provinces of Canada and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.

Advertisement
Advertisement